Hedge Fund ValueAct Bullish On Valeant Pharmaceuticals Intl Inc (VRX) – LetterRupert Hargreaves
Valeant Pharmaceuticals Intl Inc has many well-known and vocal supporters in the hedge fund industry. Bill Ackman is perhaps the most notable of these advocates, due to the hedge fund billionaire’s oversized position in the former market darling.
Jeffrey Ubben’s ValueAct Capital also owns a significant stake in the drug maker. According to the fund’s most recent 13F filing, ValueAct owned just under 15 million shares of Valeant at the end . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.